cinhyaluronate sodium (SI-614)
/ Seikagaku
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
May 16, 2023
SIDE: A Study for Evaluation of the Efficacy and Safety of SI-614 Ophthalmic Solution in Patient With Dry Eye
(clinicaltrials.gov)
- P3 | N=232 | Completed | Sponsor: Seikagaku Corporation | Active, not recruiting ➔ Completed
Trial completion • Dry Eye Disease • Ophthalmology
February 09, 2023
SIDE: A Study for Evaluation of the Efficacy and Safety of SI-614 Ophthalmic Solution in Patient With Dry Eye
(clinicaltrials.gov)
- P3 | N=232 | Active, not recruiting | Sponsor: Seikagaku Corporation | Recruiting ➔ Active, not recruiting
Enrollment closed • Dry Eye Disease • Ophthalmology
July 26, 2022
SIDE: A Study for Evaluation of the Efficacy and Safety of SI-614 Ophthalmic Solution in Patient With Dry Eye
(clinicaltrials.gov)
- P3 | N=230 | Recruiting | Sponsor: Seikagaku Corporation | Not yet recruiting ➔ Recruiting
Enrollment open • Dry Eye Disease • Ophthalmology
June 09, 2022
SIDE: A Study for Evaluation of the Efficacy and Safety of SI-614 Ophthalmic Solution in Patient With Dry Eye
(clinicaltrials.gov)
- P3 | N=230 | Not yet recruiting | Sponsor: Seikagaku Corporation
New P3 trial • Dry Eye Disease • Ophthalmology
1 to 4
Of
4
Go to page
1